This is the program for the 2010 Joint Statistical Meetings in Vancouver, British Columbia.

Keyword Search

Keyword Search Criteria: risk assessment returned 12 record(s)
Sunday, 08/01/2010
The Philosophy and Intent of Stability Shelf Life
David Christopher, Merck & Co., Inc.
3:05 PM

Benchmark Dose Analysis from Multiple Data Sets: The Cumulative Risk Assessment for N-Methyl Carbamate Pesticides
Rhyne Woodrow Setzer, U.S. Environmental Protection Agency
4:05 PM

Updated Risk Assessment of Variant Creutzfeldt-Jakob Disease (vCJD) Risks for Recipients of Blood and Plasma-Derived Products in the United States
Steven Anderson, FDA; Hong Yang, FDA; Richard Forshee, FDA; Mark Walderhaug, FDA
4:50 PM

Different Approaches to Model Averaging in Environmental Risk Assessment
Esben Budtz-Jørgensen, University of Copenhagen
5:20 PM

Monday, 08/02/2010
Risk Analysis in a Multivariate World
Xunguo Lin, CSIRO; Simon Christopher Barry, CSIRO; Vijay Satyal, Oregon Department of Energy
8:35 AM

Tuesday, 08/03/2010
Using Statistical Concepts to Determine Risk Level of Randomized Clinical Trials That Compare Two Noninvestigational Therapies
Martin L. Lesser, Feinstein Institute for Medical Research; Nina E. Kohn, Feinstein Institute for Medical Research


Benchmark Dose Estimation in Environmental Risk Assessment: From Cancer to Genetic Toxicity and Beyond
Walter W. Piegorsch, The University of Arizona
3:20 PM

Wednesday, 08/04/2010
Statistical Risk Assessment for Chemical Substances
Koji Kanefuji, The Institute of Statistical Mathematics; Takayuki Fujii, The Institute of Statistical Mathematics; Masayuki Kageyama, The Institute of Statistical Mathematics ; Masashi Gamo, National Institute of Advanced Industrial Science and Technology; Hiroe Tsubaki, The Institute of Statistical Mathematics


Application of Methods for Assessing Risk-Benefit in Clinical Trials
Menghui Chen, Merck & Co., Inc.; Shailaja Suryawanshi, Merck & Co., Inc.
9:05 AM

The Value of Personalized, Predictive Risk-Assessment Tools for the Prevention of Chronic Diseases
Edward J. Moler, Tethys Bioscience, Inc.; Louis P. Garrison, University of Washington; Janice Kolberg, Tethys Bioscience, Inc.; Harald Rinde, BioBridge Strategies Switzerland; Sean D. Sullivan, University of Washington
9:35 AM

Benefit Risk Assessment Incorporating Time Component
Paulette Ceesay, Merck & Co., Inc.; Richard Entsuah, Merck & Co., Inc.
9:50 AM

Thursday, 08/05/2010
Biomarkers in Clinical Trials in the Development of Biologics and Risk Assessment
Samir Lababidi, FDA
8:50 AM




2010 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.